Starpharma Holdings Ltd. (OTCQB: SPHRF & OTCQX: SPHRY) is a biotechnology company with two decades of experience in advancing dendrimer technology from the lab to the patient. Cheryl Maley, CEO of Starpharma joins us to discuss how its dendrimer‑based drug‑delivery platform is improving cancer therapies, advancing targeted radiopharmaceuticals, and driving value through strategic partnerships and upcoming clinical milestones.

View Podcast Transcript